BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38388710)

  • 1. Loss of EIF4G2 mediates aggressiveness in distinct human endometrial cancer subpopulations with poor survival outcome in patients.
    Meril S; Muhlbauer Avni M; Lior C; Bahlsen M; Olender T; Savidor A; Krausz J; Belhanes Peled H; Birisi H; David N; Bialik S; Scherz-Shouval R; Ben David Y; Kimchi A
    Oncogene; 2024 Apr; 43(15):1098-1112. PubMed ID: 38388710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss-of-function cancer-linked mutations in the EIF4G2 non-canonical translation initiation factor.
    Meril S; Bahlsen M; Eisenstein M; Savidor A; Levin Y; Bialik S; Pietrokovski S; Kimchi A
    Life Sci Alliance; 2024 Mar; 7(3):. PubMed ID: 38129098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss-of-function analysis reveals distinct requirements of the translation initiation factors eIF4E, eIF4E-3, eIF4G and eIF4G2 in Drosophila spermatogenesis.
    Ghosh S; Lasko P
    PLoS One; 2015; 10(4):e0122519. PubMed ID: 25849588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eukaryotic translation initiation factor eIF4G2 opens novel paths for protein synthesis in development, apoptosis and cell differentiation.
    Liu Y; Cui J; Hoffman AR; Hu JF
    Cell Prolif; 2023 Mar; 56(3):e13367. PubMed ID: 36547008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Significance of Eukaryotic Translation Initiation Factors (eIFs) in Endometrial Cancer.
    Smolle MA; Czapiewski P; Lapińska-Szumczyk S; Majewska H; Supernat A; Zaczek A; Biernat W; Golob-Schwarzl N; Haybaeck J
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA (LncRNA) SNHG7/ Eukaryotic translation initiation factor 4 gamma 2 (EIF4G2) involves in the malignant events of ovarian cancer cells with paclitaxel resistant.
    Zhang J; Zhang R; Ye Y
    Bioengineered; 2021 Dec; 12(2):10541-10552. PubMed ID: 34709112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-144-3p-mediated dysregulation of EIF4G2 contributes to the development of hepatocellular carcinoma through the ERK pathway.
    Li S; Shao J; Lou G; Wu C; Liu Y; Zheng M
    J Exp Clin Cancer Res; 2021 Feb; 40(1):53. PubMed ID: 33526055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid hormone increases bulk histones expression by enhancing translational efficiency.
    Zambrano A; García-Carpizo V; Villamuera R; Aranda A
    Mol Endocrinol; 2015 Jan; 29(1):68-75. PubMed ID: 25422881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-197 regulates chondrocyte proliferation, migration, and inflammation in pathogenesis of osteoarthritis by targeting EIF4G2.
    Gao S; Liu L; Zhu S; Wang D; Wu Q; Ning G; Feng S
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32880393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinesin Family Member C1 (KIFC1) Accelerates Proliferation and Invasion of Endometrial Cancer Cells Through Modulating the PI3K/AKT Signaling Pathway.
    Zhou K; Zhao J; Qi L; He Y; Xu J; Dai M
    Technol Cancer Res Treat; 2020; 19():1533033820964217. PubMed ID: 33034273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-139 is up-regulated in osteoarthritis and inhibits chondrocyte proliferation and migration possibly via suppressing EIF4G2 and IGF1R.
    Hu W; Zhang W; Li F; Guo F; Chen A
    Biochem Biophys Res Commun; 2016 May; 474(2):296-302. PubMed ID: 27105918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribosomal leaky scanning through a translated uORF requires eIF4G2.
    Smirnova VV; Shestakova ED; Nogina DS; Mishchenko PA; Prikazchikova TA; Zatsepin TS; Kulakovskiy IV; Shatsky IN; Terenin IM
    Nucleic Acids Res; 2022 Jan; 50(2):1111-1127. PubMed ID: 35018467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific mechanisms of translation initiation in higher eukaryotes: the eIF4G2 story.
    Shestakova ED; Smirnova VV; Shatsky IN; Terenin IM
    RNA; 2023 Mar; 29(3):282-299. PubMed ID: 36517212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-379 inhibits the proliferation, migration and invasion of human osteosarcoma cells by targetting EIF4G2.
    Xie X; Li YS; Xiao WF; Deng ZH; He HB; Liu Q; Luo W
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28381518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of EIF4G2 by miR-379 potentiates the cisplatin chemosensitivity in nonsmall cell lung cancer cells.
    Hao GJ; Hao HJ; Ding YH; Wen H; Li XF; Wang QR; Zhang BB
    FEBS Lett; 2017 Feb; 591(4):636-645. PubMed ID: 28117895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eukaryotic initiation factor 4 gamma 2 contributes to neuropathic pain through down-regulation of Kv1.2 and the mu opioid receptor in mouse primary sensory neurones.
    Zhang Z; Zheng B; Du S; Han G; Zhao H; Wu S; Jia S; Bachmann T; Bekker A; Tao YX
    Br J Anaesth; 2021 Mar; 126(3):706-719. PubMed ID: 33303185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT1-induced upregulation of lncRNA LINC01123 predicts poor prognosis and promotes the progression of endometrial cancer through miR-516b/KIF4A.
    Yang Y; Wu J; Zhou H; Liu W; Wang J; Zhang Q
    Cell Cycle; 2020 Jun; 19(12):1502-1516. PubMed ID: 32401659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. eIF4G2 balances its own mRNA translation via a PCBP2-based feedback loop.
    Smirnova VV; Shestakova ED; Bikmetov DV; Chugunova AA; Osterman IA; Serebryakova MV; Sergeeva OV; Zatsepin TS; Shatsky IN; Terenin IM
    RNA; 2019 Jul; 25(7):757-767. PubMed ID: 31010886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ_0020123 promotes non-small cell lung cancer progression via miR-146a-5p mediated regulation of EIF4G2 expression.
    Wei Z; Liu J; Hui G; Luan X
    Thorac Cancer; 2024 Jan; 15(1):44-56. PubMed ID: 37993106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel subgroup of endometrial cancer patients with loss of thyroid hormone receptor beta expression and improved survival.
    Piqué DG; Greally JM; Mar JC
    BMC Cancer; 2020 Sep; 20(1):857. PubMed ID: 32894083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.